Research on Mergers and Acquisitions and Development Trends in the Pharmaceutical Industry of State-owned Enterprises
In recent years, Chinese state-owned enterprises have been continuously acquiring medical industry companies, aiming to improve the quality and efficiency of medical services through resource integration and technological innovation, and meet the growing health needs of the people. Therefore, this p...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2024-01-01
|
| Series: | SHS Web of Conferences |
| Online Access: | https://www.shs-conferences.org/articles/shsconf/pdf/2024/27/shsconf_icdeba2024_04023.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | In recent years, Chinese state-owned enterprises have been continuously acquiring medical industry companies, aiming to improve the quality and efficiency of medical services through resource integration and technological innovation, and meet the growing health needs of the people. Therefore, this paper mainly aims to explore the results of Mergers and Acquisitions (M&A) of companies in the pharmaceutical area. It studies the characteristics and the effects of M&A of CR Pharma, Sinopharm, and Genertec. It finds out that they are a success, which reflects the motivation and strategic intention behind it. Their profits have continued to rise after M&A in general in recent years. In conclusion, consolidation has sparked several revolutionary developments that have improved market positioning, realigned strategy, and increased financial performance. Despite ongoing difficulties, these companies’ proactive effort to resolve these problems points to a bright future in the fast-paced pharmaceutical industry. The trend of M&A will continue, and the direction of M&A will also be adjusted according to the pace of economic development. |
|---|---|
| ISSN: | 2261-2424 |